Cases & Deals

Sumitomo acquires assets and rights related to lefamulin from Nabriva

Client(s) Sumitomo Pharma Co., Ltd.

Jones Day advised Sumitomo Pharma Co., Ltd. in the acquisition of assets from Nabriva Therapeutics plc and various wholly-owned subsidiaries. This acquisition includes assets from the U.S., Ireland, and Austria in support of the development, manufacture, marketing and commercialization of lefamulin in the People’s Republic of China, Hong Kong, Macau and Taiwan.